Cargando…

IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model

OBJECTIVE: Ideally, disease-modifying osteoarthritis (OA) drugs (DMOAD) should combine chondroprotective, anti-inflammatory, and analgesic effects in a single molecule. A fusion protein of interleukin-4 (IL-4) and IL-10 (IL4-10 FP) possesses these combined effects. In this study, the DMOAD activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Helvoort, E.M., de Visser, H.M., Lafeber, F.P.J.G., Coeleveld, K., Versteeg, S., Weinans, H.H, Popov-Celeketic, J., Eijkelkamp, N., Mastbergen, S.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Clinical Research papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721682/ https://www.ncbi.nlm.nih.gov/pubmed/34159843 http://dx.doi.org/10.1177/19476035211026736

Ejemplares similares

Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study
por: van Helvoort, E. M., et al.
Publicado: (2019)

The catabolic-to-anabolic shift seen in the canine osteoarthritic cartilage treated with knee joint distraction occurs after the distraction period
por: Teunissen, M., et al.
Publicado: (2022)

Groove model of tibia‐femoral osteoarthritis in the rat
por: de Visser, Huub M., et al.
Publicado: (2016)

Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
por: Oo, Win Min, et al.
Publicado: (2022)

The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date
por: Oo, Win Min, et al.
Publicado: (2021)

The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease: A Systematic Narrative Review
por: van Helvoort, E.M., et al.
Publicado: (2022)

Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model with Metabolic Dysregulation
por: de Visser, Huub M., et al.
Publicado: (2018)

Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation
por: de Visser, H. M., et al.
Publicado: (2018)

Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10
por: Steen‐Louws, C., et al.
Publicado: (2018)

Sialic Acid-Engineered IL4–10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation
por: Steen-Louws, Cristine, et al.
Publicado: (2019)

A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models
por: Sniekers, Yvonne H, et al.
Publicado: (2008)

Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathways
por: Prado, Judith, et al.
Publicado: (2021)

Advanced glycation endproducts in the development of osteoarthritis
por: DeGroot, J, et al.
Publicado: (2004)

Imaging of Folate Receptor Expressing Macrophages in the Rat Groove Model of Osteoarthritis: Using a New DOTA-Folate Conjugate
por: de Visser, Huub M., et al.
Publicado: (2017)

Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression
por: Guermazi, Ali, et al.
Publicado: (2023)

On‐demand treatment with the iron chelator deferasirox is ineffective in preventing blood‐induced joint damage in haemophilic mice
por: Pulles, Astrid E., et al.
Publicado: (2021)

The molecular profile of synovial fluid changes upon joint distraction and is associated with clinical response in knee osteoarthritis
por: Watt, F.E., et al.
Publicado: (2020)

Enhanced Extracellular Matrix Breakdown Characterizes the Early Distraction Phase of Canine Knee Joint Distraction
por: Teunissen, Michelle, et al.
Publicado: (2021)

GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohort
por: van Helvoort, Eefje M., et al.
Publicado: (2022)

Relationship between motion, using the GaitSmart(TM) system, and radiographic knee osteoarthritis: an explorative analysis in the IMI-APPROACH cohort
por: van Helvoort, Eefje M, et al.
Publicado: (2020)

Mesenchymal stem/stromal cells-derived extracellular vesicles as a potentially more beneficial therapeutic strategy than MSC-based treatment in a mild metabolic osteoarthritis model
por: Warmink, Kelly, et al.
Publicado: (2023)

Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis
por: Zweers, Manon C, et al.
Publicado: (2011)

Regulation of T cell and monocyte activation by human anergic/suppressive CD4 CD25 T cells
por: Taams, LS, et al.
Publicado: (2002)

Artificial intelligence in osteoarthritis: repair by knee joint distraction shows association of pain, radiographic and immunological outcomes
por: Jansen, Mylène P, et al.
Publicado: (2022)

NLRP3 inflammasome activation in sensory neurons promotes chronic inflammatory and osteoarthritis pain
por: Silva Santos Ribeiro, Patrícia, et al.
Publicado: (2023)

Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction
por: Sanjurjo-Rodriguez, Clara, et al.
Publicado: (2020)

Periarticular Bone Changes in Osteoarthritis
por: Weinans, Harrie
Publicado: (2012)

Knee joint distraction in regular care for treatment of knee osteoarthritis: A comparison with clinical trial data
por: Jansen, Mylène P., et al.
Publicado: (2020)

Synovial fluid hyaluronan mediates MSC attachment to cartilage, a potential novel mechanism contributing to cartilage repair in osteoarthritis using knee joint distraction
por: Baboolal, Thomas G, et al.
Publicado: (2016)

Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort
por: van Helvoort, Eefje M, et al.
Publicado: (2022)

Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers
por: van Helvoort, Eefje M, et al.
Publicado: (2020)

Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis
por: Verstappen, SMM, et al.
Publicado: (2006)

Selective elimination of inflammatory macrophages by Fcγ-RI-directed immunotoxins: a novel concept in the treatment of rheumatoid arthritis
por: van Roon, JAG, et al.
Publicado: (2002)

Baseline clinical characteristics of predicted structural and pain progressors in the IMI-APPROACH knee OA cohort
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

Identifying multivariate disease trajectories and potential phenotypes of early knee osteoarthritis in the CHECK cohort
por: Altamirano, Sara, et al.
Publicado: (2023)

Multi-classifier prediction of knee osteoarthritis progression from incomplete imbalanced longitudinal data
por: Widera, Paweł, et al.
Publicado: (2020)

Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study
por: Intema, Femke, et al.
Publicado: (2011)

Proteoglycan synthesis rate as a novel method to measure blood‐induced cartilage degeneration in non‐haemophilic and haemophilic rats
por: Pulles, Astrid E., et al.
Publicado: (2020)

Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study
por: Mastbergen, Simon C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_c5a1iqmg53m2rs0osue9d2angc